Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034067 (
emphysema
)
11,506
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The diffusion capacity for nitric oxide (DLNO) is independent of pulmonary capillary blood volume and equals the membrane diffusing capacity. Therefore the DLNO could be more sensitive in detecting alveolar destruction than the DLCO. We measured flow-volumes curves, DLNO, DLCO, the transfer coefficients
KNO
(DLNO/VA) and KCO (DLCO/VA) and performed computed tomography (CT) scans in 263 randomly selected heavy smokers. Subjects with areas > or =1% of the total lung volume showing an attenuation <-950 Hounsfield Units were considered to have
emphysema
. In 36 subjects
emphysema
was diagnosed with CT, a low
KNO
was present in 94 subjects, and in 95 subjects a FEV1/FVC ratio <70% was seen. The area under the ROC curve for detection CT-based
emphysema
was 0.894 for the
KNO
, 0.822 for the KCO and 0.795 for FEV1/FVC, meaning that the
KNO
has a slightly higher sensitivity to detect
emphysema
than the KCO and FEV1/FVC. The positive predictive value of
KNO
however was low (34.7%), while the negative predictive value of
KNO
was very high (98.2%), indicating an
emphysema
exclusion test. The DLNO/DLCO ratio is significantly higher in the study group compared to normal subjects.
...
PMID:Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers. 1958 65